Our findings in MYCN non-amplified neuroblastoma cell lines show that PGE2 enhances cell viability through the EP4 receptor, whereas this was attenuated by inhibition of PGE2 with specific COX-2 inhibitors. The gene discussed is MYCN; the disease is neuroblastoma.